| Citation: |
DENG Jiewen, SHI Shuai, TANG Weidong, YANG Xiulin, JIANG Chao, XU Cheng. Efficacy of pericardial devascularization combined with splenectomy in treatment of patients with portal hypertension[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 107-111. DOI: 10.7619/jcmp.20220241
|
To explore the clinical efficacy of pericardial devascularization (PCDV) combined with splenectomy in the treatment of patients with portal hypertension (PHT) and its influence on perioperative indicators, serum hepatocyte growth factor (HGF) and transforming growth factor-β1 (TGF-β1).
Clinical materials of 91 patients were analyzed retrospectively, and the patients were divided into observation group (53 cases, treated with selective PCDV and splenectomy) and control group (38 cases, treated with traditional PCDV and splenectomy) according to different therapeutic methods. The clinical efficacy, surgical condition and incidence of complications were compared between the two groups; the total bilirubin (TBIL), alanine aminotransferase (ALT), serum albumin (ALB) level, prothrombin time (PT), serum HGF and TGF-β1 before and after operation were compared between the two groups.
Improvement of esophagogastric varices (EGV) in the observation group was significantly better than that in the control group, the Child-Pugh score of liver function was significantly lower than that in the control group, and the difference value of free portal pressure (FPP) was significantly higher than that in the control group (P < 0.05); the operation time, intraoperative blood loss, postoperative exhaust time, drainage time and hospital stay in the observation group were significantly less or shorter than those in the control group (P < 0.05). The TBIL, ALT and PT after surgery were significantly lower than those before surgery in both groups, while the ALB was higher than that before surgery (P < 0.05); the level of serum HGF after in the observation group was significantly higher than that in the control group, while the TGF-β1 was significantly lower than that in the control group (P < 0.05). Within 3 months after operation, no pancreatic fistula, splenic abscess and hepatic encephalopathy occurred in both groups, and the incidence rates of fever and gastrointestinal rebleeding in the observation group were significantly lower than those in the control group (P < 0.05).
Selective PCDV combined with splenectomy is better than traditional non-selective PCDV combined with splenectomy in the treatment of PHT, which can enhance the ability of hepatocyte regeneration, improve liver dysfunction, and reduce the incidence of complications such as postoperative fever and gastrointestinal rebleeding.
| [1] |
ZHANG Y F, JI H, LU H W, et al. Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension[J]. World J Gastroenterol, 2018, 24(39): 4499-4509. doi: 10.3748/wjg.v24.i39.4499
|
| [2] |
崔然, 叶伦河, 王旭菁, 等. 腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压症的近期临床结果[J]. 外科理论与实践, 2021, 26(3): 221-225. https://www.cnki.com.cn/Article/CJFDTOTAL-WKLL202103014.htm
|
| [3] |
BAO H, HE Q, DAI N, et al. Retrospective study to compare selective decongestive devascularization and gastrosplenic shunt versus splenectomy with pericardial devascularization for the treatment of patients with esophagogastric varices due to cirrhotic portal hypertension[J]. Med Sci Monit, 2017, 23(1): 2788-2795.
|
| [4] |
ZHAO Y J, WANG C F. The therapeutic effect of splenectomy plus selective pericardial devascularization versus conventional pericardial devascularization on portal hypertension in China: a meta-analysis[J]. Oncotarget, 2018, 9(20): 15398-15408. doi: 10.18632/oncotarget.23857
|
| [5] |
徐小元, 丁惠国, 李文刚, 等. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. doi: 10.3969/j.issn.1001-5256.2019.11.006
|
| [6] |
李昌旭, 徐露瑶, 汝娜, 等. 腹腔镜脾脏切除贲门周围血管离断术治疗Child-Pugh A/B级肝硬化门静脉高压症的临床效果分析[J]. 临床肝胆病杂志, 2021, 37(3): 596-600. doi: 10.3969/j.issn.1001-5256.2021.03.018
|
| [7] |
孙思楠, 李建生, 余继海, 等. 选择性贲门周围血管离断术联合脾切除术治疗门静脉高压症的临床评价[J]. 肝胆外科杂志, 2017, 25(6): 416-418. doi: 10.3969/j.issn.1006-4761.2017.06.006
|
| [8] |
SHRESTHA R, THAPA J, YADAV B, et al. Endoscopic detection and management of esophagogastric varices[J]. Cureus, 2021, 13(8): e16825.
|
| [9] |
巩少军. 脾切除贲门周围血管离断术后门静脉系统血栓形成患者的肝功能评分[J]. 河北医科大学学报, 2019, 40(7): 803-806. doi: 10.3969/j.issn.1007-3205.2019.07.014
|
| [10] |
OLEVSKAYA ER, DOLGUSHINA AI, TARASOV AN, et al. Prognosis factors of survival in patients with liver cirrhosis and portal hypertension[J]. Ter Arkh, 2019, 91(2): 67-72.
|
| [11] |
YANG L P, ZHANG Z F, ZHENG J L, et al. Long-term outcomes of esophagogastric devascularization and splenectomy in patients with portal hypertension and liver cirrhosis[J]. ANZ J Surg, 2020, 90(11): 2269-2273. doi: 10.1111/ans.15994
|
| [12] |
HAO X P, DAI K F, HE Y T, et al. Laparoscopic splenectomy via the spleen bed in combination with selective esophagogastric devascularization for patients with cirrhotic portal hypertension: a single-institution experience[J]. Videosurgery Miniinv, 2020, 15(3): 462-468. doi: 10.5114/wiitm.2019.89655
|
| [13] |
邹盛海, 夏木西丁, 李忠志. 脾切除联合选择性贲门周围血管离断术治疗门静脉高压症效果分析[J]. 中国普通外科杂志, 2017, 26(6): 801-805. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201706023.htm
|
| [14] |
王蒙, 杜晓宏, 张海文, 等. 腹腔镜巨脾切除联合选择性贲门周围血管离断术治疗门静脉高压症的近期疗效评价[J]. 中华普通外科杂志, 2018, 33(7): 552-555. doi: 10.3760/cma.j.issn.1007-631X.2018.07.006
|
| [15] |
LIN J, LIU Q B, LIANG Z Q, et al. Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension[J]. Videosurgery Miniinv, 2019, 14(2): 187-194. doi: 10.5114/wiitm.2018.80297
|
| [16] |
胡智明, 江俊杰, 张焕庆, 等. 保留食管旁静脉腹腔镜选择性贲门周围血管离断术技术要点[J]. 中华肝胆外科杂志, 2021, 27(2): 98-100. doi: 10.3760/cma.j.cn113884-20200414-00197
|
| [17] |
唐俊, 朱志贤, 张焱辉, 等. 腹腔镜门静脉测压下脾切除联合选择性断流术对门静脉高压症病人的疗效及对其肝功能和预后的影响[J]. 临床外科杂志, 2019, 27(10): 901-903. doi: 10.3969/j.issn.1005-6483.2019.10.025
|
| [18] |
蒋梦真. 肝硬化门脉高压症患者血流动力学与肝储备功能的关系[J]. 中国医师杂志, 2020, 22(3): 386-390.
|
| [19] |
HUANG L, YU Q, WANG J. Association between changes in splanchnic hemodynamics and risk factors of portal venous system thrombosis after splenectomy with periesophagogastric devascularization[J]. Med Sci Monit, 2018, 24(1): 4355-4362.
|
| [20] |
YIN F, MAO LC, CAI QQ, et al. Effect of hepatocyte growth factor-transfected human umbilical cord mesenchymal stem cells on hepatic stellate cells by regulating transforming growth factor-β1/Smads signaling pathway[J]. Stem Cells Dev, 2021, 30(21): 1070-1081. doi: 10.1089/scd.2021.0136
|
| [21] |
张丹琴, 彭艳媚, 张朝阳. 门脉断流术联合脾脏切除术治疗肝硬化门静脉高压症的疗效分析[J]. 现代消化及介入诊疗, 2019, 24(8): 908-912. doi: 10.3969/j.issn.1672-2159.2019.08.023
|
| [22] |
ZHANG F, WANG F X, HE J L, et al. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1[J]. Br J Pharmacol, 2021, 178(11): 2246-2265. doi: 10.1111/bph.15289
|
| 1. |
赵肖累，谭磊，王晓波. 腹腔镜脾动脉结扎联合贲门周围血管离断术治疗肝硬化门静脉高压症的回顾性研究. 中国医学工程. 2024(03): 88-92 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: